Brian, Leyland-Jones: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

Piccart-Gebhart, Martine J., Procter, Marion, Leyland-Jones, Brian, Goldhirsch, Aron, Untch, Michael, Smith, Ian, Gianni, Luca, Baselga, Jose, Bell, Richard, Jackisch, Christian, Cameron, David, Dowse

Journal:

Boston Medical and Surgical Journal

Year:

2005

Language:

english

File:

PDF, 149 KB

english, 2005

2

Utility of genomic analysis in circulating tumor DNA from patients with carcinoma of unknown primary

Kato, Shumei, Krishnamurthy, Nithya, Banks, Kimberly C., De, Pradip, Williams, Kirstin, Williams, Casey, Leyland-Jones, Brian, Lippman, Scott M., Lanman, Richard B., Kurzrock, Razelle

Journal:

Cancer Research

Year:

2017

Language:

english

File:

PDF, 1.37 MB

english, 2017

3

Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced cancers of the gastrointestinal tract or anus

Schrock, Alexa B., Pavlick, Dean C, Klempner, Samuel J., Chung, Jon H., Forcier, Brady, Welsh, Allison, Young, Lauren, Leyland-Jones, Brian, Bordonii, Rodolfo, Carvajal, Richard D, Chao, Joseph, Kurzr

Journal:

Clinical Cancer Research

Year:

2018

Language:

english

File:

PDF, 4.71 MB

english, 2018

4

DNA derived from archival tumor specimens can be used for germline pharmacogenetic analyses

Hertz, Daniel L, Kidwell, Kelley M, Douglas, Julie A, Viale, Giuseppe, Leyland-Jones, Brian, Regan, Meredith, Rae, James M

Journal:

Pharmacogenomics

Year:

2020

File:

PDF, 336 KB

2020

5

Anthracycline analogs The past, present, and future

Raymond B. Weiss, Gisele Sarosy, Kathleen Clagett-Carr, Marianne Russo, Brian Leyland-Jones

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1986

Language:

english

File:

PDF, 1.37 MB

english, 1986

6

PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials

Dey, Nandini, De, Pradip, Leyland-Jones, Brian

Journal:

Pharmacology & Therapeutics

Year:

2017

Language:

english

File:

PDF, 775 KB

english, 2017

7

Proteomics: New technologies and clinical applications

Martin Latterich, Mark Abramovitz, Brian Leyland-Jones

Journal:

European Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 117 KB

english, 2008

8

Merbarone: an antitumor agent entering clinical trials

Alice Glover, Hoo G. Chun, Larry M. Kleinman, David A. Cooney, Jacqueline Plowman, Charles K. Grieshaber, Louis Malspeis, Brian Leyland-Jones

Journal:

Investigational New Drugs

Year:

1987

Language:

english

File:

PDF, 454 KB

english, 1987

9

A systems approach to clinical oncology: Focus on breast cancer

Mark Abramovitz, Brian Leyland-Jones

Journal:

Proteome Science

Year:

2006

Language:

english

File:

PDF, 808 KB

english, 2006

10

Hand-held Spectroscopic Device for In Vivo and Intraoperative Tumor Detection: Contrast Enhancement, Detection Sensitivity, and Tissue Penetration

Mohs, Aaron M., Mancini, Michael C., Singhal, Sunil, Provenzale, James M., Leyland-Jones, Brian, Wang, May D., Nie, Shuming

Journal:

Analytical Chemistry

Year:

2010

Language:

english

File:

PDF, 2.95 MB

english, 2010

11

Arabinosyl-5-azacytosine: A novel nucleoside entering clinical trials

Jean L. Grem, D. Dale Shoemaker, Daniel F. Hoth, Susan A. King, Jacqueline Plowman, Daniel Zaharko, Charles K. Grieshaber, Steadman D. Harrison, James C. Cradock, Brian Leyland-Jones

Journal:

Investigational New Drugs

Year:

1987

Language:

english

File:

PDF, 1022 KB

english, 1987

12

Evidence for erythropoietin as a molecular targeting agent

Brian Leyland-Jones

Journal:

Seminars in Oncology

Year:

2002

Language:

english

File:

PDF, 112 KB

english, 2002

13

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Slamon, Dennis J., Leyland-Jones, Brian, Shak, Steven, Fuchs, Hank, Paton, Virginia, Bajamonde, Alex, Fleming, Thomas, Eiermann, Wolfgang, Wolter, Janet, Pegram, Mark, Baselga, Jose, Norton, Larry

Journal:

Boston Medical and Surgical Journal

Year:

2001

Language:

english

File:

PDF, 199 KB

english, 2001

14

[Cancer Drug Discovery and Development] PI3K-mTOR in Cancer and Cancer Therapy || Phospho-Inositol-3-Kinase Activity and Dysregulation in Pediatric Leukemia and Lymphoma

Dey, Nandini, De, Pradip, Leyland-Jones, Brian

Year:

2016

Language:

english

File:

PDF, 789 KB

english, 2016

15

Role of Herceptin® in Primary Breast Cancer: Views from North America and Europe

Leyland-Jones, Brian, Smith, Ian

Journal:

Year:

2001

Language:

english

File:

PDF, 147 KB

english, 2001

16

Dose Scheduling – Herceptin®

Leyland-Jones, Brian

Journal:

Year:

2001

Language:

english

File:

PDF, 145 KB

english, 2001

17

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence

Ignatiadis, Michail, Azim, Hatem A., Desmedt, Christine, Veys, Isabelle, Larsimont, Denis, Salgado, Roberto, Lyng, Maria B., Viale, Giuseppe, Leyland-Jones, Brian, Giobbie-Hurder, Anita, Kammler, Rosi

Journal:

Year:

2015

Language:

english

File:

PDF, 428 KB

english, 2015

18

Tamoxifen metabolic patterns within a glioma patient population treated with high-dose tamoxifen

Julie Ducharme, Karen Fried, George Shenouda, Brian Leyland-Jones, Irving W. Wainer

Journal:

British Journal of Clinical Pharmacology

Year:

1997

Language:

english

File:

PDF, 254 KB

english, 1997

19

The Future of Breast Cancer Therapy: Erythropoietin as an Integral Component

Brian Leyland-Jones

Journal:

Clinical Breast Cancer

Year:

2003

Language:

english

File:

PDF, 88 KB

english, 2003

20

Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumab-refractory breast cancer model

Sun, Yuliang, Dey, Nandini, Brammer, Melissa, De, Pradip, Leyland-Jones, Brian

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 1.44 MB

english, 2013

21

Mutation matters in precision medicine: A future to believe in

Dey, Nandini, Williams, Casey, Leyland-Jones, Brian, De, Pradip

Journal:

Cancer Treatment Reviews

Year:

2017

Language:

english

File:

PDF, 1.58 MB

english, 2017

22

A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP

Brenda J. Foster, Bonnie J. Harding, Mary K. Wolpert-DeFilippes, Lawrence Y. Rubinstein, Kathleen Clagett-Carr, Brian Leyland-Jones

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1990

Language:

english

File:

PDF, 913 KB

english, 1990

23

Optimizing treatment of HER2-positive metastatic breast cancer

Alison L. Jones, Brian Leyland-Jones

Journal:

Seminars in Oncology

Year:

2004

Language:

english

File:

PDF, 141 KB

english, 2004

24

Genomic Imbalances Associated with Acquired Resistance to Platinum Analogues

Brian Leyland-Jones, Lloyd R. Kelland, Kenneth R. Harrap, Lynne R. Hiorns

Journal:

The American Journal of Pathology

Year:

1999

Language:

english

File:

PDF, 620 KB

english, 1999

25

Phase I Study of Elliptinium (2-N-Methyl-9-Hydroxyellipticinium)

Einzig, Avi I., Gralla, Richard J., Leyland-Jones, Brian R., Kelsen, David P., Cibas, Irene, Lewis, Ellen, Greenberg, And Ernest

Journal:

Cancer Investigation

Year:

1985

Language:

english

File:

PDF, 417 KB

english, 1985

26

Stereoselective pharmacokinetics of ifosfamide and its 2- and 3-N-dechloroethylated metabolites in female cancer patients

Camille P. Granvil, Julie Ducharme, Brian Leyland-Jones, Marc Trudeau, Irving W. Wainer

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1996

Language:

english

File:

PDF, 1.56 MB

english, 1996

27

Etoposide (VP-16–213)

O'Dwyer, Peter J., Leyland-Jones, Brian, Alonso, M. Teresa, Marsoni, Silvia, Wittes, Robert E.

Journal:

Boston Medical and Surgical Journal

Year:

1985

Language:

english

File:

PDF, 1.60 MB

english, 1985

28

ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer

Leyland-Jones, Brian, Gray, Kathryn P., Abramovitz, Mark, Bouzyk, Mark, Young, Brandon, Long, Bradley, Kammler, Roswitha, Dell’Orto, Patrizia, Biasi, Maria Olivia, Thürlimann, Beat, Harvey, Vernon, Ne

Journal:

Breast Cancer Research and Treatment

Year:

2015

Language:

english

File:

PDF, 706 KB

english, 2015

29

The application of a two-stage design for clinical trials in patients with recurrent head and neck cancer

Mario A. Eisenberger, Susan Ellenberg, Brian Leyland-Jones, Michael Friedman

Journal:

Pediatric Blood & Cancer

Year:

1988

Language:

english

File:

PDF, 620 KB

english, 1988

30

Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer

Angelika M. Burger, Brian Leyland-Jones, Kris Banerjee, Demetri D. Spyropoulos, Arun K. Seth

Journal:

European Journal of Cancer

Year:

2005

Language:

english

File:

PDF, 363 KB

english, 2005

31

RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers

Pradip, De, Jennifer, Carlson H., Jepperson, Tyler, Willis, Scooter, Brian, Leyland-Jones, Dey, Nandini

Journal:

Year:

2017

Language:

english

File:

PDF, 11.63 MB

english, 2017

32

2'-Fluoro-5-Iodoarabinosylcytosine, a New Potent Antiviral Agent: Efficacy in Immunosuppressed Individuals with Herpes Zoster

Brian Leyland-Jones, Harrison Donnelly, Susan Groshen, Patricia Myskowski, Alvin L. Donner, Michael Fanucchi and Jack Fox

Journal:

The Journal of Infectious Diseases

Year:

1986

Language:

english

File:

PDF, 1.14 MB

english, 1986

33

Letter to the editors

Georges Mathé, S. K. Carter, T. J. McElwain, Raymond B. Weiss, Brian Leyland-Jones

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1987

Language:

english

File:

PDF, 50 KB

english, 1987

34

Down’s Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship

Dey, Nandini, Krie, Amy, Klein, Jessica, Williams, Kirstin, McMillan, Amanda, Elsey, Rachel, Sun, Yuliang, Williams, Casey, De, Pradip, Leyland-Jones, Brian

Journal:

International Journal of Molecular Sciences

Year:

2017

Language:

english

File:

PDF, 3.36 MB

english, 2017

35

Didemnin B

Hoo G. Chun, Barbara Davies, Daniel Hoth, Matthew Suffness, Jacqueline Plowman, Karl Flora, Charles Grieshaber, Brian Leyland-Jones

Journal:

Investigational New Drugs

Year:

1986

Language:

english

File:

PDF, 508 KB

english, 1986

36

Serum HER2 testing in patients with HER2-positive breast cancer: the death knell tolls

Brian Leyland-Jones, Brian R Smith

Journal:

The Lancet Oncology

Year:

2011

Language:

english

File:

PDF, 105 KB

english, 2011

37

Promise of rapalogues versus mTOR kinase inhibitors in subset specific breast cancer: Old targets new hope

De, Pradip, Miskimins, Keith, Dey, Nandini, Leyland-Jones, Brian

Journal:

Cancer Treatment Reviews

Year:

2013

Language:

english

File:

PDF, 718 KB

english, 2013

38

[Cancer Drug Discovery and Development] PI3K-mTOR in Cancer and Cancer Therapy || The AKT-mTOR Signaling Pathway for Drug Response Prediction and Prognostic Signatures

Dey, Nandini, De, Pradip, Leyland-Jones, Brian

Year:

2016

Language:

english

File:

PDF, 305 KB

english, 2016

39

Dasatinib attenuates overexpression of Src signaling induced by the combination treatment of veliparib plus carboplatin in triple-negative breast cancer

Sun, Yuliang, Lin, Xiaoqian, Aske, Jennifer Carlson, Ye, Ping, Williams, Casey, Abramovitz, Mark, Leyland-Jones, Brian R.

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2019

Language:

english

File:

PDF, 3.23 MB

english, 2019

40

5-methyltetrahydrohomofolate

Peter J. O'Dwyer, Barbara H. Wagner, Daniel F. Hoth, Brian Leyland-Jones

Journal:

Investigational New Drugs

Year:

1987

Language:

english

File:

PDF, 301 KB

english, 1987

41

Erythropoietin as a critical component of breast cancer therapy: survival, synergistic, and cognitive applications

Brian Leyland-Jones, Joyce A O’Shaughnessy

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 142 KB

english, 2003

42

Molecular determinants of trastuzumab efficacy: What is their clinical relevance?

De, Pradip, Hasmann, Max, Leyland-Jones, Brian

Journal:

Cancer Treatment Reviews

Year:

2013

Language:

english

File:

PDF, 711 KB

english, 2013

43

PROTEIN-CODING AND MICRORNA BIOMARKER GENE PANELS PREDICTIVE OF CLINICAL RECURRENCE IN PROSTATE CANCER

Petros, John A, Lai, Yu-Heng, Seth, Arun, Osunkoya, Adeboye O, Zhou, Wei, Johnson, Brent A, Nam, Robert, Barwick, Benjamin, Abramovitz, Mark, Bouzyk, Mark, Leyland-Jones, Brian, Moreno, Carlos S

Journal:

The Journal of Urology

Year:

2009

Language:

english

File:

PDF, 60 KB

english, 2009

44

PULMONARY AND NEUROLOGIC COMPLICATIONS OF TREATMENT WITH FIAC (2'FLUORO-5-IODO-ARACYTOSINE) IN PATIENTS WITH ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)

Gold, Jonathan W. M., Leyland-Jones, Brian, Urmacher, Carlos, Armstrong, Donald

Journal:

Year:

1983

Language:

english

File:

PDF, 674 KB

english, 1983

45

Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms

Schwaederle, Maria, Zhao, Melissa, Lee, J. Jack, Lazar, Vladimir, Leyland-Jones, Brian, Schilsky, Richard L., Mendelsohn, John, Kurzrock, Razelle

Journal:

Year:

2016

Language:

english

File:

PDF, 376 KB

english, 2016

46

[Cancer Drug Discovery and Development] PI3K-mTOR in Cancer and Cancer Therapy || PI3K-Akt-mTOR Signaling in Cancer and Cancer Therapeutics

Dey, Nandini, De, Pradip, Leyland-Jones, Brian

Year:

2016

Language:

english

File:

PDF, 222 KB

english, 2016

47

Management of hepatic metastases from colorectal cancer: systemic chemotherapy

Brian Leyland-Jones, Susan Burdette-Radoux

Journal:

Journal of Gastrointestinal Surgery

Year:

1997

Language:

english

File:

PDF, 558 KB

english, 1997

48

Breast cancer trial with erythropoietin terminated unexpectedly

Brian Leyland-Jones

Journal:

The Lancet Oncology

Year:

2003

Language:

english

File:

PDF, 85 KB

english, 2003

49

Identification of N1-methyl-2-pyridone-5-carboxamide and N1-methyl-4-pyridone-5-carboxamide as components in urine extracts of individuals consuming coffee

Pierre Wong, Abderrazak Bachki, Kris Banerjee, Brian Leyland-Jones

Journal:

Journal of Pharmaceutical and Biomedical Analysis

Year:

2002

Language:

english

File:

PDF, 140 KB

english, 2002

50

Hexamethylmelamine: A critical review of an active drug

Brenda J. Foster, Bonnie J. Harding, Brian Leyland-Jones, Daniel Hoth

Journal:

Cancer Treatment Reviews

Year:

1986

Language:

english

File:

PDF, 1.16 MB

english, 1986

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски